Loading

GOVERNMENT

  • by Danielle Keane, NORML Political Director April 27, 2016

    lobby_day_2016We are excited to have finalized the agenda for our 2016 National Conference and Congressional Lobby Day! You can check out the full itinerary here.

    Day one will include panel discussions on a variety of topics, including the prospects of marijuana law reform in the 114th Congress, the ongoing experience with legalization in Colorado, Washington, and other states, and post prohibition concerns for marijuana consumers. Throughout the day attendees will hear policy experts from NORML, the Marijuana Policy Project, Americans for Safe Access, the National Cannabis Industries Association, and many others

    NORML’s Conference seminar takes place on Monday, May 23rd, at the GW Elliot School of International Affairs located at 1957 E Street NW in Washington D.C. Register now here.

    Following the seminar, attendees will head to the Mansion on O Street (2020 O St NW) for our NORML Social. Here, attendees will kick back and relax with fellow advocates and share stories of their activism. We will also be holding our 2016 Awards Ceremony, to honor our most dedicated activists and shine light on the hard work they’ve put in throughout the years. You won’t want to miss this event and entry is not included in your general Lobby Day registration. You can purchase a separate ticket to the NORML Social here.

    On Tuesday morning attendees will meet on Capitol Hill for a morning reception to hear from our allies in Congress who are leading federal marijuana law reform efforts. Following that, attendees will separate into groups based on voting district/state and together will visit their federally elected officials offices to discuss with them the importance of ending the federal prohibition of marijuana.

    **If you’re already registered to attend our 2016 Congressional Lobby Day, please contact your federally elected officials Washington D.C. office to schedule an appointment to talk with a staffer on Tuesday, May 24th. Walk-ins are generally not supported. If you have questions or would like assistance with this please email danielle@norml.org.**

    If your organization would like to help support NORML’s 2016 Congressional Lobby Day please consider becoming a sponsor! More information on sponsorships is available here.

    We can’t wait to gather like minded activists, volunteers, lobbyists, and marijuana consumers all together under one roof to discuss the state of marijuana law reform around the country, to honor our MVP’s of the movement and to lobby our federally elected officials together. Register today!

  • by Danielle Keane, NORML Political Director April 20, 2016

    NORML Congressional ScorecardNORML would like to wish you a Happy 4/20! In honor of the annual holiday we are pleased to release our 2016 Congressional Scorecard.

    With 61 percent of  American adults now advocating that “the use of marijuana should be made legal,” and 67 percent of voters believing states, not the federal government, ought to be the ultimate arbiters of marijuana regulatory policy, it’s no longer acceptable for the federal government to continue to be an impediment to progress.

    Do you know where your federally elected officials stand?

    Our Congressional Scorecard  is an all-encompassing database that assigns a letter grade ‘A’ through ‘F’ to members of Congress based on their marijuana-related comments and voting records.

    Below are some key findings from the Scorecard:

    NORML Congressional ScorecardAmong the 535 members of the 114th Congress:

    • 312 members (58 percent) received a passing grade of ‘C’ or higher (258 Representatives and 54 Senators)
    • Nineteen members (3.6 percent) received a grade of ‘A’ (17 Representatives and 2 Senators) and 37 members (6.9 percent) received failing grade (20 Representatives and 17 Senators)
    • Of the 233 Democrats in Congress, 208 members (89.3 percent) received a passing grade of a ‘C’ or higher.
    • Of the 302 Republicans in Congress, 102 members (33.8 percent) received a passing grade of a ‘C’ or higher.

    You can access the complete 2016 Congressional Scorecard here.

    You can read our Executive Summary here.

    Projects like this are only possible because of the donations from NORML members. If you find our Congressional Scorecard useful and wish to support NORML’s efforts, please make a donation of at least $4.20 on this 4/20.

    Thank you for your continued support and Happy 4/20,
    -The NORML Team

    P.S. Don’t forget to attend NORML’s 2016 Congressional Lobby Day, May 23-24 in Washington, DC.

  • by Danielle Keane, NORML Political Director April 14, 2016

    thumbs_upThere is long awaited news from Pennsylvania, as the Keystone State is poised to become the 24th state to permit medical cannabis access and separate legislative efforts continue to move forward around the country. Keep reading below to get this week’s latest in marijuana law reform!

    Federal:

    The U.S. Senate Appropriations Committee approved an amendment today, for the second year in a row, to expand medical marijuana access to United States veterans.

    The amendment, sponsored by Senators Steve Daines (R-MT) and Jeff Merkley (D-OR), would prohibit the Department of Veterans Affairs (V.A.) from spending money to enforce a policy that prohibits the department’s physicians from filling out medical marijuana recommendation forms in states where the drug is legal. It will be attached to the Military Construction and Veterans Affairs Appropriations bill.

    The bipartisan vote was 20 to 10, marking a slight improvement from last year’s 18-12 vote. Though a majority of the Senate passed the amendment in 2015, it was ultimately defeated in conference with the House.

    State:

    Alabama: Legislation to protect qualified patients eligible for CBD therapy is gaining traction in the legislature. Both the House and Senate are considering similar proposals to expand patient access. While existing state law permits qualified patients to use CBD if they are part of state-sponsored clinical trial, these proposed measures would legally protect qualified patients who possess the substance outside of a clinical trial environment. #TakeAction

    Florida: Another municipality in Florida is considering decriminalizing offenses involving the possession of small amounts of marijuana. On Monday, Orlando’s City Council will review an ordinance to make possession of 20 grams (about two-thirds of an ounce) or less a violation of city code, punishable by a fine of $50 for first-time offenders. Tampa and Volusia County both approved similar ordinances last month. NORML first reported this trend of Florida cities and counties adopting decriminalization policies last August.

    If you live in Orlando, you can contact your City Council member to urge their support for this measure here.

    Louisiana: House and Senate legislation is pending to fix and expand the state’s dormant medical marijuana law. Existing law only permits for the patients’ use of medical marijuana in instances where the plant is ‘prescribed.’ However, under federal law, physicians cannot legally ‘prescribe’ cannabis or any schedule I substance. House Bill 1112 addresses these problems by: permitting physicians to recommend rather than ‘prescribe’ cannabis therapy; by licensing facilities to produce and dispense the product; and by expanding the pool of eligible patients to include ailments like cancer, multiple sclerosis, Crohn’s disease and intractable pain. Law enforcement groups have voiced disapproval of the proposed change, so it is important that lawmakers hear from you. #TakeAction

    Maryland: Governor Larry Hogan has signed legislation to permit the Department of Agriculture to authorize institutions of higher education to cultivate industrial hemp for academic research purposes. Members of the Senate voted 45 to zero in favor of the bill. House members voted 136 to zero in favor of the measure. Maryland is the 26th state to enact legislation recognizing hemp as a agricultural commodity.

    State lawmakers have also approved legislation to expand the pool of medical professionals who can provide written recommendations for marijuana to qualifying patients. Under the proposal, nurse midwives and nurse practitioners, among other medical professionals, who are in good standing with the state will be permitted to provide written certifications to qualifying patients. The legislation awaits action from Governor Larry Hogan. #TakeAction

    Oregon: Governor Kate Brown has signed legislation into law that seeks to encourage financial institutions to engage in financial relationships with state-compliant marijuana businesses. The emergency legislation, House Bill 4094, “exempts financial institutions that provide financial services to marijuana related businesses, researchers and laboratories from any criminal law of this state.” The law took effect upon signing.

    pills_v_potPennsylvania: House and Senate lawmakers have given final approval to legislation, Senate Bill 3, to permit the production and use of medical marijuana products to qualified patients. Members of the Senate initially approved the measure in 2015. House leadership delayed acting on the bill for several months until finally passing an amended version of SB 3 in March. Senate and House members voted this week in favor of a concurrent version of the proposal. Once signed into law, Pennsylvania will become the 24th state to permit the use of physician-recommended cannabis.

    South Carolina: Members of the Senate Medical Affairs Committee have defeated SB 672, the Medical Marijuana Program Act. However, identical legislation, H. 4037, remains pending in the House. The legislation would allow the use of medical marijuana for debilitating medical conditions; it also permits a registered patient or caregiver to possess up to, “two one-ounce packages of marijuana in leaf form, one ounce of cannabis oil concentrate, or eight ounces of diluted cannabis oil.” #TakeAction

    Vermont: Members of the House Judiciary moved away from Senate-backed legislation, S. 241, to regulate the adult use, production, and sale of cannabis. On Friday, April 8, members of the Committee voted 6 to 5 on an amended version of S. 241 to establish a study commission to evaluate the matter of legalization. The vote came after members of the committee narrowly rejected an effort to amend the bill in a manner that would expand the state’s existing decriminalization laws.

    Members of the Senate previously voted 17 to 12 in favor of the legislation in its original form, and it continues to be backed by Gov. Shumlin, state Attorney General William Sorrell, and a majority of Vermonters. It is vital that members of both the House and Senate continue hear from you in support of S. 241 so that lawmakers will be persuaded to once again amend this bill in a manner that seeks to regulate the adult use, production, and sale of cannabis. #TakeAction

  • by Danielle Keane, NORML Political Director April 8, 2016

    map_leafWe’ve got several legislative updates from around the country this week. Keep reading below to get the latest in marijuana law reform!

    State:

    Colorado: Denver NORML filed the Responsible Use initiative with the city of Denver. If passed by voters this November, it would legalize the establishment of private marijuana clubs for adults 21 and up. Passage of this ordinance would be a historic first step in moving toward normalizing the responsible, adult consumption of marijuana. The initiative would provide adults with a legally defined space where marijuana could be consumed and shared with other like-minded citizens — a simple, yet necessary accommodation for states that have passed some form of legalization. You can show support for the initiative by liking their page on Facebook.

    Florida: On April 1st, the city of Tampa began implementing its new decriminalization law. Under the new ordinance, people caught with 20 grams or less of marijuana will now only face a civil citation rather than a arrest, criminal prosecution, and a criminal record.

    Also, The Florida Democratic Party has endorsed Amendment 2, a constitutional amendment to permit the physician-authorized use and state-licensed distribution of cannabis for therapeutic purposes. The initiative has also received recent endorsements from the Tallahassee Democrat, the Miami Herald, and the Bradenton Herald. Presently, 16 states explicitly exempt the use of CBD by qualified patients. But, to date, no of these states provide a regulated, in-state supply source for the product.

    Maine: A superior court judge today overturned the Secretary of State’s ruling that a citizen petition seeking to legalize recreational marijuana in Maine was invalid. The ruling mandates the Secretary of State to review the disputed signatures to determine whether petitioners submitted enough valid ones to qualify for ballot placement this November.

    Missouri: This week, regulators at the Missouri Department of Agriculture granted licenses to two applicants seeking to grow CBD-dominant cannabis. Their products are anticipated to be ready for distribution this fall to state-qualified patients.

    Pennsylvania: State lawmakers have unanimously passed separate pieces of legislation to establish “a pilot program to study the growth, cultivation or marketing of industrial hemp.” Members of the Senate voted 49 to zero in March in favor of SB 50. House lawmakers more recently voted 187 to zero in favor of the House companion bill, HB 967. House Bill 967 will now go to the Senate  for concurrence with SB 50 and then to Gov. Tom Wolf, who has expressed support for the legislation. #TakeAction

    Members of the Pittsburgh City Council have approved a new ordinance imposing more lenient penalties for minor marijuana possession offenses. Under this ordinance, marijuana-related offenses will now be classified as summary offenses, punishable by a fine of $100 for public smoking or $25 for the possession of a small amount of marijuana.

    Virginia: Governor Terry McAuliff has signed legislation, Senate Bill 701, into law to establish regulations governing the in-state production of therapeutic oils high in cannabdiol and/or THC-A (THC acid). Senate Bill 701 requires the Board of Pharmacy to adopt regulations establishing health, safety, and security requirements for pharmaceutical processors of oils high in CBD and/or THC-A. The measure takes effect on July 1, 2016.

    Don’t forget to join us in Washington D.C. May 23rd and 24th for our 2016 Congressional Lobby Day! Whether you are a longtime activist, a young college student, a medical marijuana patient, a social marijuana consumer, or just someone who opposes prohibition, this is an opportunity to meet like-minded individuals from across the country and get a glimpse into the Capitol Hill lawmaking process. It is an exhilarating experience for anyone who has taken the time to come to DC to lobby their members of Congress. Get your tickets today!

  • by Danielle Keane, NORML Political Director April 5, 2016

    marijuana_gavelMembers of the Senate Caucus on International Narcotics Control, lead by Senate Judiciary Chairman, Chuck Grassley (R-IA) gathered this morning for a hearing titled, “Is the Department of Justice Adequately Protecting the Public from the Impact of State Recreational Marijuana Legalization?”

    Invited participants at today’s hearing included an advisory board member for a national anti-marijuana organization and the Nebraska Attorney General who sought to overturn Colorado’s marijuana regulation laws by filing a lawsuit with the Supreme Court. Clearly, Senator Grassley and co-chair, Senator Feinstein (D-CA) did not gather lawmakers to discuss how to move marijuana policy reform forward, but backwards.

    Senator Grassley’s hearing appeared, by and large, to be an effort to try and shame the Department of Justice into taking action to overturn the regulatory laws of states that are presently regulating marijuana production and sale. The panelists presented a laundry list of purported dangers that they claimed to be the result of changes in marijuana laws, such as supposed spikes in teenage use and traffic collisions.

    There was, however, one highlight for marijuana reformers during today’s hearing. When witness Benjamin B. Wagner, U.S. Attorney of the Eastern District of California, Sacramento, California was asked by Sen. Grassley as to why the Department of Justice isn’t challenging adult use marijuana state laws, he responded: “The decision to intervene would not be solely based on data. If we took out regulation of the market and just left decriminalization, it may leave a more chaotic system than it is now.”

    By contrast, arguably the hearing’s lowlight came from Senator Jeff Sessions (R-AL), who spoke longingly of about the decade of ‘Just Say No’ and claimed, “[G]ood people don’t smoke marijuana.”

    The hearing’s tone, while predictable, is nonetheless disappointing. That is because the CARERS Act, bipartisan legislation to strengthen statewide medical marijuana protections, is pending before the US Judiciary Committee, chaired by Sen. Grassley. To date, the senator has pledged not to hear the bill, despite the fact that medical marijuana legalization is supported by 80 percent of his own constituents and an estimated 78 percent of voters nationwide.

    If you live in Iowa, you can contact Senator Grassley and urge him to hold hearings on the CARERS Act here. If you don’t live in Iowa, you can urge your own elected officials to support the CARERS Act here.

    To view an archived video of today’s Congressional hearing, please visit: http://www.drugcaucus.senate.gov/hearings.

Page 5 of 107« First...34567...102030...Last »